Susceptibility to Hepatitis B Virus Infection Among People Who Inject Drugs in Montreal, Canada
Drug and Alcohol Review · 2025-07 · 44 (5) · 1526-1532
DOI: 10.1111/dar.14091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, online erschienen am 03.06.2025. Verfasst von Olivia Price und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Introduction
People who inject drugs are at elevated risk of hepatitis B virus (HBV) infection, which is preventable by vaccination. We examined susceptibility to HBV infection among a sample of people who inject drugs and live in Montreal, Canada.
Methods
Data were obtained from HEPCO, a prospective cohort study of people who had recently (within the past six months) injected drugs, between November 2022 and March 2024. The absence of hepatitis B surface antibody indicated susceptibility to HBV infection. These results were compared to self‐report immune status. Logistic regression was used to identify factors associated with HBV susceptibility.
Results
Overall, 28.1% (108/384) of participants were susceptible to HBV infection. Over half (60.2%, 231/384) of participants correctly reported their immune status. Individuals born in Canada prior to the introduction of universal childhood vaccination programs had higher odds of susceptibility to HBV infection (adjusted odds ratio: 2.63, 95% confidence interval: 1.34–5.61), while those in opioid agonist treatment (0.60, 0.37–0.98) and with a history of hepatitis C infection (0.51, 0.32–0.83) had lower odds of HBV susceptibility. Discussion and Conclusions An important minority of people who inject drugs in Montreal remain susceptible to HBV infection. Moderate concordance between self‐report and serological results indicates that serology or vaccine registry information should continue to be used to inform immunisation provision. People who inject drugs who were born prior to childhood vaccination programs and/or are not in opioid agonist treatment are subpopulations who require targeted interventions to increase vaccination coverage.
Autor:innen und Institutionen
- National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
- Centre de Recherche du Centre Hospitalier de L'université de Montréal, Montréal, Canada.
- Department of Family Medicine and Emergency Medicine, Faculty of Medicine, University of Montréal, Montréal, Canada.
- Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, University of Montréal, Montréal, Canada.
ORCID-Profile: Olivia Price, Sarah Larney, Julie Bruneau
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Price, O., Larney, S., Martel-Laferrière, V., Bruneau, J., & Harney, B. (2025). Susceptibility to Hepatitis B Virus Infection Among People Who Inject Drugs in Montreal, Canada. Drug and Alcohol Review, 44(5), 1526-1532. https://doi.org/10.1111/dar.14091
Vancouver
Price O, Larney S, Martel-Laferrière V, Bruneau J, Harney B. Susceptibility to Hepatitis B Virus Infection Among People Who Inject Drugs in Montreal, Canada. Drug and Alcohol Review. 2025;44(5):1526-1532. doi:10.1111/dar.14091
BibTeX
@article{Price2025,
author = {Price, Olivia and Larney, Sarah and Martel-Laferrière, Valerie and Bruneau, Julie and Harney, Brendan},
title = {Susceptibility to Hepatitis B Virus Infection Among People Who Inject Drugs in Montreal, Canada},
journal = {Drug and Alcohol Review},
year = {2025},
volume = {44},
number = {5},
pages = {1526--1532},
doi = {10.1111/dar.14091}
}
EUVIMED